DERIVATIVES OF 1-(3-AMINOPHENYL)-6,8-DIMETHYL-5-(4-IODO-2-FLUORO-PHENYLAMINO)-3-CYCLOPROPYL-1H,6H-PYRIDO[4,3-d]PYRIMIDINE-2,4,7-TRIONE AS MEK1/2 INHIBITORS Russian patent published in 2016 - IPC C07D487/04 A61K31/519 A61K35/00 

Abstract RU 2605400 C1

FIELD: chemistry.

SUBSTANCE: present invention relates to novel derivatives of 1-(3-aminophenyl)-6,8-dimethyl-5-(4-iodo-2-fluoro-phenylamino)-3-cyclopropyl-1H, 6H-pyrido[4,3-d]pyrimidine-2,4,7-trione, having effect on kinase MEK1 and can be used for treating and preventing cancer, in particular malignant melanoma. Said derivatives are selected from following group of compounds: N-{3-[6,8-dimethyl-5-(4-iodo-2-fluoro-phenylamino)-3-cyclopropyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-2-dimethylaminoacetamide hydrochloride (1.1), N-{3-[6,8-dimethyl-5-(4-iodo-2-fluoro-phenylamino)-3-cyclopropyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-2-dimethylaminopropionamide hydrochloride (1.4), N-{3-[6,8-dimethyl-5-(4-iodo-2-fluoro-phenylamino)-3-cyclopropyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-2-dimethylaminobutyramide hydrochloride (1.7), (R)-{3-[6,8-dimethyl-5-(4-iodo-2-fluoro-phenylamino)-3-cyclopropyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-2-dimethylaminopropionamide hydrochloride (1.10), {3-[6,8-dimethyl-5-(4-iodo-2-fluoro-phenylamino)-3-cyclopropyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-amide(R)-1-methylpyrrolidine-2-carboxylic acid hydrochloride (1.14). Invention also relates to a method of producing said compounds.

EFFECT: method consists in that compound of formula 2 or salt thereof: , where R2 is a hydrogen atom, reacts with corresponding organic acid or an activated derivative thereof, with subsequent treatment of obtained product with hydrogen chloride solution.

11 cl, 1 tbl, 7 ex

Similar patents RU2605400C1

Title Year Author Number
N-{3-[3-CYCLOPROPYL-5-(2-FLUORO-4-IODOPHENYLAMINO)-6,8-DIMETHYL-2,4,7-TRIOXO-3,4,6,7-TETRAHYDRO-2H-PYRIDO[4,3-D]PYRIMIDINE-1-IL]-PHENYL}-CYCLOPROPANECARBOXAMIDE DIMETHYLSULFOXIDE SOLVATE AS MEK1/2 INHIBITOR 2016
  • Ivashchenko Aleksandr Vasilevich
  • Ignatev Vasilij Gennadevich
  • Repik Aleksej Evgenevich
  • Shafeev Mikhail Ajratovich
RU2627692C1
SUBSTITUTED N-{3-[4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YLAMINO]-4-METHOXYPHENYL}-AMIDES AS MODULATORS OF EGFR, APPLICABLE FOR TREATING CANCER 2015
  • Ivashchenko Aleksandr Vasilevich
  • Ignatev Vasilij Gennadevich
  • Repik Aleksej Evgenevich
  • Shafeev Mikhail Ajratovich
RU2606949C9
SUBSTITUTED METHYL(2-{4-[3-(3-METHANESULFONYLAMINO-2-FLUORO-5-CHLORO-PHENYL)-1H-PYRAZOL-4-YL]PYRIMIDIN-2-YLAMINO}ETHYL) CARBAMATES, PROCESS FOR THEIR PREPARATION AND APPLICATION 2016
  • Ivashchenko Aleksandr Vasilevich
  • Ignatev Vasilij Gennadevich
  • Repik Aleksej Evgenevich
  • Shafeev Mikhail Ajratovich
RU2615986C1
SUBSTITUTED N2-(4-AMINO-2-METHOXYPHENYL)-N4-[2-(DIMETHYLPHOSPHORYL)-PHENYL]-5-CHLORO-PYRIMIDINE-2,4-DIAMINES AS MODULATORS OF ALK AND EGFR, APPLICABLE FOR TREATING CANCER 2015
  • Ivashchenko Aleksandr Vasilevich
  • Ignatev Vasilij Gennadevich
  • Repik Aleksej Evgenevich
  • Shafeev Mikhail Ajratovich
RU2607371C1
DICHLOROACETATES OF SUBSTITUTED N4-[2-(DIMETHYLPHOSPHORYL)PHENYL]-N2-(2-METHOXY-4-PIPERIDIN-1-YLPHENYL)-5-CHLOROPYRIMIDINE-2,4-DIAMINES AS MODULATORS OF ALK AND EGFR, INTENDED FOR TREATING CANCER 2015
  • Ivashchenko Aleksandr Vasilevich
  • Ignatev Vasilij Gennadevich
  • Repik Aleksej Evgenevich
  • Shafeev Mikhail Ajratovich
RU2606951C1
8-(1-{4-{(5-CHLORO-4-{(2-(DIMETHYLPHOSPHORYL)PHENYL)AMINO}PYRIMIDIN-2-YL)AMINO)-3-METHOXYPHENYL}PIPERIDIN-4-YL)-1-METHYL-1,8-DIAZASPIRO(4.5)DECAN-2-ONE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS AS AN ALK AND EGER MODULATOR FOR TREATMENT OF CANCER 2017
  • Ivashchenko Aleksandr Vasilevich
  • Ignatev Vasilij Gennadevich
  • Repik Aleksej Evgenevich
  • Shafeev Mikhail Ajratovich
RU2654695C1
{3-[(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)AZOLYL]AZETIDIN-3-YL} ACETONITRILES AS JANUS KINASE INHIBITORS 2015
  • Ivashchenko Aleksandr Vasilevich
  • Ignatev Vasilij Gennadevich
  • Repik Aleksej Evgenevich
  • Shafeev Mikhail Ajratovich
RU2601410C1
PYRIDYL KETONE DERIVATIVES, METHOD OF PREPARING SAME AND PHARMACEUTICAL APPLICATION THEREOF 2014
  • Tu Vanyan
  • Chzhan Khajtan
  • Syuj Gotszi
  • Chi Tszyantao
RU2667892C2
DICHLOROACETATE OF N,N-DISUBSTITUTED N-[4-(1-METHYL-1H-INDOLE-3-YL)-PYRIMIDINE-2-YL]-5-METHOXYBENZENE-1,2,4-TRIAMINE AS EGFR MODULATOR FOR TREATING CANCER 2015
  • Ivashchenko Aleksandr Vasilevich
  • Ignatev Vasilij Gennadevich
  • Repik Aleksej Evgenevich
  • Shafeev Mikhail Ajratovich
RU2603960C1
PRODRUG OF TRIAZOLONE COMPOUND 2011
  • Klark Richard
  • Matsuura Fumiesi
  • Sinoda Masanobu
  • Khirota Sinsuke
  • Kira Kazunobu
  • Azuma Khirosi
  • Takemura Atsusi
  • Jasui So
  • Kusano Kazutomi
  • Mikamoto Masaki
  • Omae Takao
RU2581369C2

RU 2 605 400 C1

Authors

Ivashchenko Aleksandr Vasilevich

Ignatev Vasilij Gennadevich

Repik Aleksej Evgenevich

Shafeev Mikhail Ajratovich

Dates

2016-12-20Published

2015-11-13Filed